期刊文献+

肿瘤抗原基因MAGE-3的克隆、原核表达与纯化 被引量:1

Cloning, prokaryotic expression and purification of tumor antigen gene MAGE-3
下载PDF
导出
摘要 目的 :克隆人MAGE 3基因并进行原核表达和分离纯化 .方法 :通过RT PCR从人黑色素瘤细胞株中扩增MAGE 3全长cDNA ,经PCR扩增MAGE 3基因 3′端 32 4bp片段 ,克隆入pGEX 4T 1载体 ,构建重组原核表达质粒pGEX/MAGE 3,对含有该质粒的大肠杆菌DH5α进行诱导表达和分离纯化 .结果 :经RT PCR扩增出大小约 95 0bp的基因片段 ,以此为模板经PCR扩增出约 32 0bp片段 ,测序结果与Gen Bank公布的MAGE 3序列一致 ,成功构建了pGEX/MAGE 3原核表达质粒 ,经IPTG诱导在大肠杆菌中表达Mr 约 4 2 0 0 0的GST融合蛋白 ,纯化的蛋白纯度为 89% .结论 :成功克隆了人MAGE 3基因全长cDNA并对其 3′端 32 4bp片段编码的 1 0 8个氨基酸的蛋白进行了原核表达和分离纯化 。 AIM: To clone human MAGE 3 gene, to induce its prokaryotic expression and to purify the protein. METHODS: Full length cDNA of MAEG 3 gene was amplified by RT PCR from human melanoma cell line. 3′ terminal 324 bp segment of MAGE 3 gene was amplified by PCR. After the gene was sequenced, it was cloned into the expression vector pGEX 4T 1 to construct the expression plasmid pGEX/MAGE 3. The DH5αcontaining the expression plasmid was induced. RESULTS: The sequence of the amplified segment was identical with that reported in GenBank. The expression plasmid pGEX/MAGE 3 was successfully constructed. The DH5α containing the plasmid expressed a Mr 42 000 fusion protein after being induced by IPTG. Its purity was 89%. CONCLUSION: The full length cDNA of MAEG 3 gene was cloned. The 108 aa segment of MAGE 3 encoded by 3′ terminal 324 bp of gene is expressed and purified successfully, which lays a foundation for the application of the protein in tumor immunotherapy.
出处 《第四军医大学学报》 北大核心 2004年第6期485-488,共4页 Journal of the Fourth Military Medical University
基金 国家自然科学基金资助项目 (30 2 71 4 64) 全军医药卫生科研基金重点资助项目 (0 1Z0 84)
关键词 MAGE-3 克隆 分子 基因表达 纯化 MAGE 3 cloning, molecular gene expression purification
  • 相关文献

参考文献8

  • 1[1]Chomez P,DeBacker O,Bertrand M,et al.An overview of the MAGE gene family with the identification of all human members of the family [J].Cancer Res,2001;61(14):5544-5551.
  • 2[4]Kocher T,Schultz-Thater E,Gudat F,et al.Identification and intracellular location of MAGE-3 gene product [J].Cancer Res,1995;55(11):2236-2239.
  • 3[5]Coulie PG,Karanikas V,Colau D,et al.A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3 [J].Proc Natl Acad Sci USA,2001;98(18):10290-10306.
  • 4[6]Nishiyama T,Tachibana M,Horiguchi Y,et al.Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide [J].Clin Cancer Res,2001;7(1):23-36.
  • 5[7]Marchand M,van Baren N,Weynants P,et al.Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1 [J].Int J Cancer,1999;80(2):219-230.
  • 6[8]Sadanaga N,Nagashima H,Mashino K,et al.Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas [J].Clin Cancer Res,2001;7(8):2277-2784.
  • 7[9]Coulie PG,Karanikas V,Lurquin C,et al.Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen [J].Immunol Rev,2002;188(1):33-42.
  • 8[10]Zeuthen J,Dzhandzhugazyan K,Hansen MR,et al.The immunogenic properties of human melanomas and melanoma-associated antigens recognized by cytotoxic T lymphocytes [J].Bratisl Lek Listy,1998;99(8-9):426-438.

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部